Skip to main content

Animations

MJFF Publications

3851 - 3860 of 6433 Results
Title
Year
  • Year
  • 2018
  • 2017
  • 2018
  • 2024
  • 2015
  • 2016
  • 2012
  • 2018
  • 2018
  • 2023
  • Summary Details
    OPEN
    Title: Joint modeling of multivariate longitudinal data and survival data in several observational studies of Huntington’s disease
    Journal Name: BMC Medical Research Methodology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12874-018-0592-9
    Citation Count: 54
  • Summary Details
    OPEN
    Title: Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson’s case
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-017-0482-0
    Citation Count: 114
  • Summary Details
    OPEN
    Title: Parkin deficiency modulates NLRP3 inflammasome activation by attenuating an A20‐dependent negative feedback loop
    Journal Name: Glia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/glia.23337
    Citation Count: 133
  • Summary Details
    OPEN
    Title: Identification and In Vitro and In Vivo Characterization of KAC-50.1 as a Potential α-Synuclein PET Radioligand
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acschemneuro.4c00493
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa, publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.neuron.2015.11.018
    Citation Count: 249
  • Summary Details
    OPEN
    Title: Effects of LRRK2 Inhibitors on Nigrostriatal Dopaminergic Neurotransmission
    Journal Name: CNS Neuroscience & Therapeutics
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1111/cns.12660
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Daytime alertness in Parkinson's disease: Potentially dose‐dependent, divergent effects by drug class
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.25082
    Citation Count: 48
  • Summary Details
    OPEN
    Title: Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4)
    Journal Name: Journal of Neuropathology & Experimental Neurology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/jnen/nly056
    Citation Count: 35
  • Summary Details
    OPEN
    Title: Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.02.007
    Citation Count: 126
  • Summary Details
    OPEN
    Title: Scaling of an antibody validation procedure enables quantification of antibody performance in major research applications
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.91645.2
    Citation Count: 32
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.